Controlling a key protein that regulates blood cell development
Direct chemical control of the hematopoietic master transcription factor PU.1
This study is exploring new ways to quickly adjust a key protein that helps make blood cells, which could lead to better treatments for people with blood cancers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10540346 on NIH RePORTER |
What this research studies
This research focuses on the direct chemical control of PU.1, a master transcription factor essential for the development of blood cells. Instead of relying on genetic methods that can take hours to show effects, this project aims to develop faster chemical approaches to manipulate PU.1 activity. By using innovative techniques like phage display to identify peptides that can enhance or inhibit PU.1's function, the research seeks to provide a more immediate and effective way to influence blood cell formation and address related blood cancers. This could lead to new therapeutic strategies for patients with hematopoietic malignancies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with hematopoietic malignancies, such as acute myeloid leukemia, who may benefit from novel therapeutic approaches targeting PU.1.
Not a fit: Patients with non-hematological cancers or those without blood cell disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and safer treatments for blood cancers by providing new ways to control blood cell development.
How similar studies have performed: While the approach of direct chemical control is innovative, similar strategies targeting transcription factors have shown promise in other studies, indicating potential for success.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Poon, Gregory Man Kai — Georgia State University
- Study coordinator: Poon, Gregory Man Kai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.